Adia Med Inc (ADIA)
OQB · Financial Services · Shell Companies
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About Adia Med Inc
Adia Nutrition, Inc. offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as PivX Solutions Inc. and changed its name to Adia Nutrition, Inc. in May 2004. Adia Nutrition, Inc. is based in Winter Park, Florida.
Quarterly Financials
| Metric | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Revenue | 72K | 176K |
| Gross Profit | 14K | 68K |
| Operating Income | -111K | -152K |
| Net Income | -116K | -163K |
| Diluted EPS | $0.00 | $0.00 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 6K | 701K |
| Gross Profit | 2K | 192K |
| Operating Income | -175K | -366K |
| Net Income | -181K | -395K |
| Diluted EPS | $0.00 | $0.00 |